| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology, University of Colorado Medical Center, Denver, Colorado 80262
BeWo is a malignant human choriocarcinoma line derived from a methotrexate-resistant tumor. Under normal conditions, two BeWo phenotypes coexist in culture. The predominant form, 96 to 99% of the total population, consists of cytotrophoblast-like (CTL) cells that are proliferative, mononucleate, and moderate in size. The remaining cells are syncytiotrophoblast-like (STL), being giant, nonproliferative, and multinucleated. Treatment of BeWo cultures with 1 µM methotrexate causes a total inhibition of cell division but does not stop nuclear division or DNA or protein synthesis. Consequently, there arises a population of giant, multinucleated, nonproliferative cells that is morphologically indistinguishable from the naturally occurring STL cells. CTL BeWo cells possess prominent surface ruffles, contain moderate numbers of microvilli and filopodia, contain a prominent network of interlacing filament bundles, and are connected by fascia adherens and desmosomes. STL BeWo cells are 3 to 10 times larger than CTL's; have reduced ruffles, filopodia, cytoplasmic filament bundles, and desmosome and fascia adherens junctions; but possess increased microvilli, Golgi apparatus, smooth and dilated endoplasmic reticulum, and a variety of vesicles and granules. The methotrexate induction of STL cells is reversible upon drug removal. A comparison of our observations with literature data for the normal in utero trophoblast indicates that CTL BeWo cells are ultrastructurally similar to cells of the cytotrophoblast, while STL BeWo cells are ultrastructurally similar to the normal syncytiotrophoblast. Our findings indicate that the BeWo line provides an excellent culture model system for investigating the nontoxic, cytodifferentiative changes that chemotherapeutic agents induce in human tumor cells and raise the possibility that the BeWo line may also prove a valuable culture model system for the investigation of mammalian trophoblast development.
1 These studies were supported in part by an American Cancer Society Institutional Research Grant and by National Cancer Institute Grants CA-16154 and CA-23985. A portion of this work was presented at the American Society of Cell Biology Meeting, San Diego, Calif. 1977 (7).
Received 1/18/78. Accepted 2/27/79.
This article has been cited by other articles:
![]() |
S. Anand, G. Honari, T. Hasan, P. Elson, and E. V. Maytin Low-Dose Methotrexate Enhances Aminolevulinate-Based Photodynamic Therapy in Skin Carcinoma Cells In vitro and In vivo Clin. Cancer Res., May 15, 2009; 15(10): 3333 - 3343. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.K. Harris, R.J. Keogh, M. Wareing, P.N. Baker, J.E. Cartwright, G.S. Whitley, and J.D. Aplin BeWo cells stimulate smooth muscle cell apoptosis and elastin breakdown in a model of spiral artery transformation Hum. Reprod., November 1, 2007; 22(11): 2834 - 2841. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Mani, J. R. Hammond, J. M. J. Marjan, K. A. Graham, J. D. Young, S. A. Baldwin, and C. E. Cass Demonstration of Equilibrative Nucleoside Transporters (hENT1 and hENT2) in Nuclear Envelopes of Cultured Human Choriocarcinoma (BeWo) Cells by Functional Reconstitution in Proteoliposomes J. Biol. Chem., November 13, 1998; 273(46): 30818 - 30825. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Doss, N. C. Ramirez, and W. D. Lawrence Failed Methotrexate-Treated Ectopic Pregnancies: Clinicopathologic Correlations International Journal of Surgical Pathology, October 1, 1997; 5(3-4): 83 - 93. [Abstract] [PDF] |
||||
![]() |
E Renault and J Deschatrette Inductive effect of copper deficiency on the reversion of dedifferentiated rat hepatoma cells and on gene amplification J. Cell Sci., January 11, 1994; 107(11): 3251 - 3258. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |